Using liposomes conjugated with an E-selectin–binding peptide, Li et al. performed targeted co-delivery of hypolipidemic and anti-oxidation drugs in vivo and observed atherosclerosis inhibition in a traditional ApoE−/− murine atherosclerosis model [72]. This evidence concerns the gene APOE and atherosclerosis.